PHR.WA
Price:
$3.05
Market Cap:
$33.97M
Pharmena S.A., a biotechnology company, manufactures and sells active ingredients in various areas of medicines in Poland and internationally. The company offers dermatological cosmetics, including skin, hair, and nail care products, as well as dietary supplement for atherosclerosis prophylaxis. It offers its products under the Menavitin, Dermena, Allerco, and Thermi names. The company is developing 1-MNA, an anti-atherosclerosis drug which is under phase II clinical trial. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. is a subsidiary of Pelion S.A.
Industry
Biotechnology
IPO Date
2008-08-01
Stock Exchange
WSE
Ticker
PHR.WA
According to Pharmena S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -16.05. This represents a change of -60.26% compared to the average of -40.39 of the last 4 quarters.
The mean historical PE Ratio of Pharmena S.A. over the last ten years is -47.07. The current -16.05 PE Ratio has changed 3.31% with respect to the historical average. Over the past ten years (40 quarters), PHR.WA's PE Ratio was at its highest in in the September 2016 quarter at 1.08K. The PE Ratio was at its lowest in in the September 2018 quarter at -5355.01.
Average
-47.07
Median
-36.76
Minimum
-131.73
Maximum
2.73
Discovering the peaks and valleys of Pharmena S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 171.68%
Maximum Annual PE Ratio = 2.73
Minimum Annual Increase = -1337.07%
Minimum Annual PE Ratio = -131.73
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -33.80 | -1337.07% |
| 2023 | 2.73 | -106.88% |
| 2022 | -39.73 | 107.58% |
| 2021 | -19.14 | 33.40% |
| 2020 | -14.35 | 154.39% |
| 2019 | -5.64 | -95.72% |
| 2018 | -131.73 | 67.12% |
| 2017 | -78.82 | -15.55% |
| 2016 | -93.34 | 64.00% |
| 2015 | -56.91 | 171.68% |
The current PE Ratio of Pharmena S.A. (PHR.WA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-23.60
5-year avg
-20.86
10-year avg
-47.07
Pharmena S.A.’s PE Ratio is less than Urteste S.A. (-12.44), less than Airway Medix S.A. (19.28), less than Pure Biologics Spólka Akcyjna (-1.35), less than NanoGroup S.A. (-12.86), less than BioMaxima S.A. (68.99), less than Adiuvo Investments S.A. (6.32), less than Genomtec S.A. (-5.56), less than Poltreg S.A. (-4.57), less than Molecure S.A. (-4.97), less than Mabion S.A. (-3.33),
| Company | PE Ratio | Market cap |
|---|---|---|
| -12.44 | $51.73M | |
| 19.28 | $36.35M | |
| -1.35 | $33.30M | |
| -12.86 | $90.06M | |
| 68.99 | $48.43M | |
| 6.32 | $8.56M | |
| -5.56 | $66.28M | |
| -4.57 | $111.46M | |
| -4.97 | $150.20M | |
| -3.33 | $129.62M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharmena S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pharmena S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Pharmena S.A.'s PE Ratio?
How is the PE Ratio calculated for Pharmena S.A. (PHR.WA)?
What is the highest PE Ratio for Pharmena S.A. (PHR.WA)?
What is the 3-year average PE Ratio for Pharmena S.A. (PHR.WA)?
What is the 5-year average PE Ratio for Pharmena S.A. (PHR.WA)?
How does the current PE Ratio for Pharmena S.A. (PHR.WA) compare to its historical average?